Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1094 Articles

Chris Lange | Jan 24, 2016 at 10:15 AM EST

Top DJIA Earnings for the Week Ahead

24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies (and others) that…

Jon C. Ogg | Jan 20, 2016 at 7:50 AM EST

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Investors need to keep in mind that the downside target for the Dow Jones Industrial Average will sink lower if…

Chris Lange | Jan 19, 2016 at 11:20 AM EST

Johnson & Johnson Plans to Cut Roughly 3,000 Jobs in Medical Devices

Johnson & Johnson is looking to save some money over the next few years and as a result it is…

Chris Lange | Jan 6, 2016 at 10:35 AM EST

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

24/7 Wall Street has evaluated three major Dow components in the pharmaceutical industry and presented the bullish and bearish case…

Douglas A. McIntyre | Oct 27, 2015 at 11:00 AM EDT

The 10 Most Profitable Companies in the World

ThinkstockIn the second quarter of this year, U.S. corporate profits totalled $1.8 trillion after taxes. Massive corporate profit is not…

Chris Lange | Oct 23, 2015 at 4:09 PM EDT

Janssen Secures Approval From FDA on New LPS and LMS Drug

ThinkstockJanssen Biotech announced that the U.S. Food and Drug Administration (FDA) approved Yondelis (trabectedin) for the treatment of patients with…

Paul Ausick | Oct 15, 2015 at 4:01 PM EDT

The 4 Stocks That Dominated the Dow on Thursday

ThinkstockOctober 15, 2015: Markets opened higher on Thursday following a strong showing for stocks in both Asia and Europe. Biotech…

Paul Ausick | Oct 13, 2015 at 8:05 AM EDT

Johnson & Johnson Raises Forecast, Adds $10 Billion Buyback Plan

Johnson & Johnson reported mixed third-quarter 2015 results before markets opened Tuesday morning.

Chris Lange | Oct 12, 2015 at 1:55 PM EDT

What to Expect From Johnson & Johnson Earnings

Johnson & Johnson is scheduled to report its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 11, 2015 at 9:25 AM EDT

Top Dow Earnings in the Coming Week

24/7 Wall St. has put together a preview of some of the Dow Jones Industrial Average companies that are reporting…

Jon C. Ogg | Oct 5, 2015 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AutoZone, Discover, IBM, Microsoft, Twitter, Viacom, Wynn and Many More

Monday's top analyst upgrades, downgrades and initiations include AutoZone, Discover Financial Services, IBM, Microsoft, Twitter, Viacom and Wynn Resorts.

Chris Lange | Sep 17, 2015 at 9:55 AM EDT

Achillion Pharma Rises on Solid Interim Results

Its stock has suffered, but it is possible that Achillion’s interim trial results may have put the company back on…

Paul Ausick | Sep 3, 2015 at 4:01 PM EDT

The 4 Stocks That Weighed on the DJIA Thursday

thinkstockSeptember 3, 2015: Markets opened higher on Thursday after the European Central Bank president indicated that the ECB would continue quantitative…

Paul Ausick | Aug 28, 2015 at 4:01 PM EDT

The 4 Stocks That Held Down the DJIA on Friday

thinkstockAugust 28, 2015: Markets opened lower on Friday, and except for a brief visit above the break-even line, the blue…

Paul Ausick | Aug 24, 2015 at 1:35 PM EDT

Dow Stocks Recover 90% of Opening Loss

Led by Apple and Intel, the Dow 30 stocks have engineered a significant recovery since the opening bell rang Monday…

1 … 34 35 36 37 38 … 73

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Top DJIA Earnings for the Week Ahead

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Johnson & Johnson Plans to Cut Roughly 3,000 Jobs in Medical Devices

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

The 10 Most Profitable Companies in the World

Janssen Secures Approval From FDA on New LPS and LMS Drug

The 4 Stocks That Dominated the Dow on Thursday

Johnson & Johnson Raises Forecast, Adds $10 Billion Buyback Plan

What to Expect From Johnson & Johnson Earnings

Top Dow Earnings in the Coming Week

Top Analyst Upgrades and Downgrades: AutoZone, Discover, IBM, Microsoft, Twitter, Viacom, Wynn and Many More

Achillion Pharma Rises on Solid Interim Results

The 4 Stocks That Weighed on the DJIA Thursday

The 4 Stocks That Held Down the DJIA on Friday

Dow Stocks Recover 90% of Opening Loss

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

Top DJIA Earnings for the Week Ahead

Bearish DJIA Case in 2016 Drops to 14,961 From 15,076: Chevron, Goldman Sachs, Intel, IBM, JPMorgan, Disney

Johnson & Johnson Plans to Cut Roughly 3,000 Jobs in Medical Devices

The 2016 Bullish and Bearish Case for Pfizer, Merck, Johnson & Johnson

The 10 Most Profitable Companies in the World

Janssen Secures Approval From FDA on New LPS and LMS Drug

The 4 Stocks That Dominated the Dow on Thursday

Johnson & Johnson Raises Forecast, Adds $10 Billion Buyback Plan

What to Expect From Johnson & Johnson Earnings

Top Dow Earnings in the Coming Week

Top Analyst Upgrades and Downgrades: AutoZone, Discover, IBM, Microsoft, Twitter, Viacom, Wynn and Many More

Achillion Pharma Rises on Solid Interim Results

The 4 Stocks That Weighed on the DJIA Thursday

The 4 Stocks That Held Down the DJIA on Friday

Dow Stocks Recover 90% of Opening Loss

Jill Schlesinger Greenlights $2.9M Retiree’s $200K Gift to Sons: ‘I Can’t Believe I’m Being the Dream Maker’

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts

Rivian Tops Q1 Estimates, but Investors Investors Rightly Remain Wary

Featured Reads

Jill Schlesinger Greenlights $2.9M Retiree's $200K Gift to Sons: 'I Can't Believe I'm Being the Dream Maker'

Why 56% of Americans Are Losing the Inflation Fight Before Retirement Even Starts